Yoshiko Sano

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

The Improvement of Sweet Taste Sensitivity with Decrease in Serum Leptin Levels During Weight Loss in Obese Females

Mika Umabiki, Kokoro Tsuzaki, Kazuhiko Kotani et al. · The Tohoku Journal of Experimental Medicine · 2010 · 86 citations · Full text

Agriculture, Genetics, Nutrition +17

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 79 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Short-Term Low Calorie Diet Intervention Reduces Serum Advanced Glycation End Products in Healthy Overweight or Obese Adults

Alejandro Gugliucci, Kazuhiko Kotani, Jennifer Taing et al. · Annals of Nutrition and Metabolism · 2009 · 60 citations

Agriculture, Nutrition, Nutritional Sciences +12

Eculizumab improves fatigue in refractory generalized myasthenia gravis

Henning Andersen, Renato Mantegazza, Jing Jing Wang et al. · Quality of Life Research · 2019 · 56 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14